InvestSMART

Trajan Group Holdings Limited (ASX:TRJ)

ALERT: Price-sensitive ASX Announcement for TRJ
Current share price for TRJ : $0.260 -0.03 (-10.34%)+
Announcement
Release
8 Oct 2026 8:57AM
Price at Release
$0.290
Full Release
download
Summary
Trajan Group Holdings Limited’s ShareWise Webinar presentation, titled "Understanding Trajan: Our progress so far and the journey ahead", introduces TRJ as a global developer and manufacturer of analytical and life science products and devices with about 600 staff across ten sites in the US, Australia, Europe and Asia, operating mainly through Components & Consumables, Capital Equipment and a small Disruptive Technologies segment, and emphasises its diversified products, customers, geographies and channels to market. The presentation outlines Trajan’s growth since its 2011 founding through a mix of organic expansion and acquisitions, its step-wise integration strategy, and its focus on nEBITDA as a core measure of underlying business health. For FY26, revenue was $161.4 million, down 3.1%, group nEBITDA was $13.2 million, down 14.7%, proforma gross margin was 38.9%, down 0.8 percentage points, operating NPATA was $2.2 million, up 191.3%, cash was $12.6 million and net debt was $34.6 million, with results affected by sustained Australian dollar appreciation against the USD and EUR during the second half of FY26; however, management highlighted an H2 FY26 improvement driven by cost reductions, pricing actions and supply chain initiatives, including $1.2 million uplift from Project Neptune, a further $1.2 million from reduced corporate services headcount, a 3.2 percentage point H2 gross margin increase over H1, about $0.9 million of supply chain savings, and a reduction of 45.4 FTE from September to June entering FY27 with fewer than 600 FTE. The FY27 Q1 update indicated continuing momentum, with unaudited quarterly nEBITDA of about $3.5 million, rolling 12-month nEBITDA of $16.2 million, net revenue up 3.8% year on year, including 5.2% growth in Components & Consumables and 12.7% growth in Disruptive Technologies, while Capital Equipment remained soft at down 1.2%, and net debt fell by $1.6 million; based on this momentum since Q2 FY26, Trajan guided to mid-single digit organic revenue growth and double-digit nEBITDA growth in FY27, noting further guidance would be provided at the AGM on Wednesday, 28 October 2026 at 10:00 am AEDT.
Key Points
  • The presentation is a ShareWise Webinar by Trajan Group Holdings Limited dated 08 October 2026 and presented by CEO and Managing Director Stephen Tomisich.
  • Trajan describes itself as a global purpose-led developer and manufacturer of analytical and life science products and devices founded in 2011.
  • Trajan operates across three segments: Components & Consumables at about 70% of revenue, Capital Equipment at about 30%, and Disruptive Technologies at less than 1%.
  • The company has approximately 600 staff across ten manufacturing and operations sites in the US, Australia, Europe and Asia, with more than 95% of revenue generated outside Australia.
  • Trajan highlighted a step-wise acquisition and integration model aimed at retaining talent, building efficiencies, controlling timing and costs, and supporting sustainable growth.
  • FY26 group revenue was $161.4 million, down 3.1% from the prior comparable period.
  • FY26 group nEBITDA was $13.2 million, down 14.7% from the prior comparable period.
  • FY26 proforma gross margin was 38.9%, down 0.8 percentage points, while operating NPATA rose to $2.2 million.
  • Cash at FY26 year end was $12.6 million and net debt was $34.6 million.
  • Management said AUD appreciation in H2 FY26 negatively affected reported revenue, with about 85% of revenues derived in USD and EUR.
  • H2 FY26 performance improved through Project Neptune savings, lower corporate services headcount, pricing actions from 1 January 2026 and supply chain initiatives.
  • Headcount was reduced by 45.4 FTE from September to June 2026, and the group entered FY27 with under 600 FTE.
  • Unaudited FY27 Q1 nEBITDA was about $3.5 million, taking rolling 12-month nEBITDA to $16.2 million.
  • FY27 Q1 net revenue was up 3.8%, with Components & Consumables up 5.2%, Disruptive Technologies up 12.7% and Capital Equipment down 1.2%.
  • Net debt reduced by $1.6 million in FY27 Q1.
  • Trajan guided to mid-single digit organic revenue growth and double-digit nEBITDA growth for FY27 relative to the prior comparable period.
  • The company said more specific FY27 revenue and nEBITDA targets would be provided at its AGM on 28 October 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.